OXIS International, Inc.

Type: Public
On the web: http://www.oxis.com
Employees: 1
Employee growth: (66.7%)

Don't stress out -- call OXIS International. The company specializes in researching and treating conditions related to oxidative stress, in which low antioxidant levels throw off metabolic balance at the cellular level. OXIS is focused on the development of nutritional and cosmeceutical products, including formulations for use in OTC food supplements and skin products. Its ERGO (L-Ergothioneine) antioxidant product line treats anti-inflammatory ailments and other health conditions. OXIS also licenses out compounds to biotech and pharmaceutical companies.

Key numbers for fiscal year ending December, 2011:
Sales: $0.0M
One year growth: 136.4%
Net income: ($3.7)M

Officers:
Chairman and CEO: Anthony J. (Tony) Cataldo
President: Bernie Landes
CFO: Michael D. Handelman

Competitors:
Alticor
NBTY
Pharmavite LLC